COYA: the cashflow

MyFinsight

For the quarter ending 2025-09-30, COYA had -$1,627,462 decrease in cash & cash equivalents over the period.

Unit: Dollar

Cash Flow	2025-09-30	2025-06-30
Collaboration revenue	3,985,754	-
Total research and development expenses	11,794,054	-
In-process research and development	515,996	-
Total general and administrative expenses	8,179,521	-
Depreciation	6,840	-
Other income	1,006,772	-
Net loss	-2,115,831	-13,401,734
Depreciation	6,840	13,680
Stock-based compensation, including the issuance of restricted stock	1,070,892	2,115,795
Acquired in-process research and development assets	515,996	-
Prepaids and other current assets	224,625	-2,298,347
Accounts payable	180,358	-656,784
Accrued expenses	-1,199,979	1,450,625
Deferred collaboration revenue	635,746	-421,500
Net cash used in operating activities	-1,130,603	-8,601,571
Purchase of in-process research and development assets	515,996	-
Net cash used in investing activities	-515,996	-
Proceeds from the exercise of stock options	19,137	19,137
Net cash provided by financing activities	19,137	19,137
Net decrease in cash and cash equivalents	-1,627,462	-8,582,434
Cash and cash equivalents at beginning of period	38,339,762	-
Cash and cash equivalents at end of period	28,129,866	-

Unit: Dollar